Latest

immunotherapy

This shows a depressed person and a pill bottle.

·May 20, 2026·12 min read

Arthritis Drug Rescues Hard-to-Treat Depression

The anti-inflammatory drug tocilizumab can successfully induce remission in patients struggling with treatment-resistant depression.

Brain Cancer Featured Neurology Neuroscience

·May 12, 2026·13 min read

Personalized DNA Vaccine Doubles Glioblastoma Survival Rates

A "first of its kind" personalized DNA vaccine is doubling survival rates for patients with aggressive glioblastoma. By targeting 40 unique tumor proteins, twice as many as previous therapies, the GNOS-PV01 vaccine transforms "cold" tumors into "hot" targets for the immune system. With one patient remaining cancer-free five years late.

Featured Genetics Neurology Neuroscience

·March 5, 2026·10 min read

Single-Injection Immunotherapy That Halts Alzheimer’s

Scientists engineer a single-injection "cellular immunotherapy" that turns ordinary brain cells into amyloid-eating super cleaners.

This shows a brain with cancer cells being blasted away by a laser.

Brain Cancer Featured Neurology Neuroscience

·February 26, 2026·8 min read

Laser Heat Unlocks Immunotherapy for Brain Cancer

Scientists use laser heat to "unseal" the blood-brain barrier, allowing immunotherapy to achieve record-breaking survival rates for brain cancer.

This shows the HIV virus and blood cells.

Featured Neurology Neuroscience

·December 1, 2025·7 min read

Scientists Achieve Sustained HIV Control Without Lifelong Drugs

Scientists tested a multi-step immune-based therapy designed to retrain the body to control HIV without continuous antiviral treatment. After stopping standard HIV drugs, seven out of ten participants maintained low viral levels for extended periods, and one showed no viral rebound at all.

Featured Neurology Neuroscience

·October 2, 2024·4 min read

Personalized Immune Therapy Offers Hope for MS Patients

A new study explores the use of tolerogenic dendritic cells (tolDCs) to restore immune balance in multiple sclerosis (MS) patients without compromising their immune system. The research reveals that MS patients’ immune cells have a pro-inflammatory signature, even after being modified for therapy.

Brain Cancer Featured Neurology Neuroscience

·May 9, 2024·7 min read

Breakthrough in Immunotherapy for Brain Cancer

Researchers unveiled a new combination immunotherapy that significantly boosts the immune response in patients with malignant gliomas. By integrating a personalized dendritic cell vaccine with poly-ICLC, an immune-boosting agent, the therapy has shown promise in enhancing the dendritic cells' capacity to combat this aggressive brain tumor.

This shows a doctor looking at brain scans.

Featured Neurology Neuroscience

·April 3, 2024·6 min read

Immunotherapy Shows Promise as Alzheimer’s Treatment

Researchers unveiled a novel approach to combat Alzheimer’s disease by activating microglia, the brain's immune cells, to devour amyloid beta plaques, a hallmark of the condition. This study highlights the potential of using immunotherapy to not only tackle Alzheimer’s but also other neurodegenerative diseases characterized by harmful protein accumulations.

Brain Cancer Featured Neurology Neuroscience

·June 2, 2023·6 min read

Promising Phase 2 Trial Results for Pembrolizumab in Metastatic Brain Cancer

A phase 2 clinical trial of pembrolizumab has shown promising results, with 42% of patients with metastatic brain cancer benefiting from the treatment. The trial found that pembrolizumab, an immunotherapy, was tolerated and demonstrated clinical benefit in patients with brain metastases.

Brain Cancer Featured Neurology Neuroscience

·April 13, 2023·3 min read

Personalized Immunotherapy to Fight Deadly Brain Tumors

Researchers are testing a new personalized immunotherapy approach that is designed to work similarly to a vaccine by training the immune system to fight glioblastoma brain cancer.

Featured Neurology Neuroscience

·December 6, 2022·5 min read

Immunotherapy Eliminates Disease-Causing Cells in Multiple Sclerosis-Like Disease

CAR-T, a therapy generally used in the treatment of cancer, has been shown to eliminate unhealthy cells that trigger autoimmunity in mouse models of multiple-sclerosis.

This shows the outline of a head and brain

Brain Cancer Featured Neurology Neuroscience

·June 6, 2022·5 min read

How the Gut Microbiome Impacts Immunotherapy Response in Glioblastoma Brain Cancer

Researchers say the gut microbiome may be a viable targetable biomarker to improve immunotherapy responses in those with glioblastoma and a range of other cancers.

1 2 3 4

immunotherapy

Arthritis Drug Rescues Hard-to-Treat Depression

Personalized DNA Vaccine Doubles Glioblastoma Survival Rates

Single-Injection Immunotherapy That Halts Alzheimer’s

Laser Heat Unlocks Immunotherapy for Brain Cancer

Scientists Achieve Sustained HIV Control Without Lifelong Drugs

Personalized Immune Therapy Offers Hope for MS Patients

Breakthrough in Immunotherapy for Brain Cancer

Immunotherapy Shows Promise as Alzheimer’s Treatment

Promising Phase 2 Trial Results for Pembrolizumab in Metastatic Brain Cancer

Personalized Immunotherapy to Fight Deadly Brain Tumors

Immunotherapy Eliminates Disease-Causing Cells in Multiple Sclerosis-Like Disease

How the Gut Microbiome Impacts Immunotherapy Response in Glioblastoma Brain Cancer

Astrocyte Sodium Levels Vary to Match Local Synaptic Needs

Serotonin Proven to Reduce Cognitive Belief Stickiness in OCD

Psilocybin Resets Brain Pain Networks and Boosts Painkillers

Heart Attacks Release Toxin That Damages Brain Function

Subscribe